Mining Majors Join Forces to Sponsor Virax HIV Drug Clinical Trial in South Africa
Rights Issue Raises $2.36 million to Date
Change of Substantial Shareholder Interest
Funding for Southern Africa Trial & Minimum Subscription Exceeded
Clinical Trial Application Lodged with US FDA & Extension of Rights Issue Closing Date
Prospectus - $4.1 million Pro-Rata Rights Issue
Application Lodged to Conduct an HIV Clinical Trial in South Africa - 4 September 2006
Milestone Update & Appendix 4E
Notice of Substantial Shareholding
Milestone Update and Appendix 4D
Rights Issue Raises $3.7 million
Pro-Rata Share Issue Raises $3.1 million
Captial Raising Passes 50% Subscription
Rights Issue Minimum Subscription Reached